Literature DB >> 2502064

Postantibiotic effect of penicillin plus gentamicin versus Enterococcus faecalis in vitro and in vivo.

M T Hessen1, P G Pitsakis, M E Levison.   

Abstract

A persistent suppression of bacterial growth following a brief exposure to an antibiotic (postantibiotic effect [( PAE]) has been described for a variety of antibiotics and microorganisms. If a PAE is present in vivo, antibiotic levels in tissue at the site of infection may decrease below the MIC without bacterial regrowth in the latter portion of the dosing interval. In the present studies, a PAE was sought in vitro and in vivo for penicillin G plus gentamicin versus Enterococcus faecalis. The studies demonstrated that increasing concentrations of gentamicin caused an increased rate of bactericidal action and an increasingly prolonged PAE in vitro. The combination of penicillin and gentamicin, in addition to more rapid killing, exhibited a more prolonged PAE than did penicillin alone. However, unlike these in vitro findings, no PAE could be demonstrated in vivo in rats with experimental left-sided enterococcal endocarditis treated with penicillin plus gentamicin. This suggests that antibiotic vegetation levels should be maintained above the MIC throughout the dosing interval to prevent loss of efficacy as a result of bacterial regrowth.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502064      PMCID: PMC172498          DOI: 10.1128/AAC.33.5.608

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Experimental bacterial endocarditis. II. Survival of a bacteria in endocardial vegetations.

Authors:  D T Durack; P B Beeson
Journal:  Br J Exp Pathol       Date:  1972-02

2.  Postantibiotic effects.

Authors:  B S Vogelman; W A Craig
Journal:  J Antimicrob Chemother       Date:  1985-01       Impact factor: 5.790

3.  Newly made enzymes determine ongoing cell wall synthesis and the antibacterial effects of cell wall synthesis inhibitors.

Authors:  E Tuomanen
Journal:  J Bacteriol       Date:  1986-08       Impact factor: 3.490

4.  Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time.

Authors:  P J McDonald; W A Craig; C M Kunin
Journal:  J Infect Dis       Date:  1977-02       Impact factor: 5.226

5.  Absence of a postantibiotic effect in experimental Pseudomonas endocarditis treated with imipenem, with or without gentamicin.

Authors:  M T Hessen; P G Pitsakis; M E Levison
Journal:  J Infect Dis       Date:  1988-09       Impact factor: 5.226

6.  Enterococcal endocarditis.

Authors:  C J Wilkowske
Journal:  Mayo Clin Proc       Date:  1982-02       Impact factor: 7.616

7.  The postantibiotic effect in the treatment of experimental meningitis caused by Streptococcus pneumoniae in rabbits.

Authors:  M G Täuber; O Zak; W M Scheld; B Hengstler; M A Sande
Journal:  J Infect Dis       Date:  1984-04       Impact factor: 5.226

8.  The importance of pharmacodynamics in determining the dosing interval in therapy for experimental pseudomonas endocarditis in the rat.

Authors:  M J Ingerman; P G Pitsakis; A F Rosenberg; M E Levison
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

9.  Rat model of experimental endocarditis.

Authors:  J Santoro; M E Levison
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

10.  Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.

Authors:  K Ries; M E Levison; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

View more
  14 in total

1.  Increasing Antimicrobial Resistance: Therapeutic Implications for Enterococcal Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

Review 2.  In vivo antibiotic synergism: contribution of animal models.

Authors:  B Fantin; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

Review 3.  Continuous infusion of beta-lactam antibiotics.

Authors:  W A Craig; S C Ebert
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

4.  Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin.

Authors:  J Gavaldà; A Pahissa; B Almirante; M Laguarda; E Crespo; L Pou; F Fernández
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

5.  Gentamicin volume of distribution in critically ill septic patients.

Authors:  C Triginer; I Izquierdo; R Fernández; J Rello; J Torrent; S Benito; A Net
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

6.  Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis.

Authors:  M Blatter; U Fluckiger; J Entenza; M P Glauser; P Francioli
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

Review 7.  Versatility of aminoglycosides and prospects for their future.

Authors:  Sergei B Vakulenko; Shahriar Mobashery
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

8.  Synergistic activity of ceftriaxone combined with netilmicin administered once daily for treatment of experimental streptococcal endocarditis.

Authors:  P B Francioli; M P Glauser
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

9.  Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum.

Authors:  J Gavaldà; P J Cardona; B Almirante; J A Capdevila; M Laguarda; L Pou; E Crespo; C Pigrau; A Pahissa
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

Review 10.  Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides.

Authors:  G G Zhanel; W A Craig
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.